merck gardasil china - Search News

Merck shares plunge

Hosted on MSN · 9h

Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook

Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.

Associated Press · 14h

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

BioPharma Dive · 39m

Merck shares tumble as company pauses Gardasil shipments to China

Executives pulled back on a 2030 sales target of $11 billion as demand for the HPV shot shrinks amid China market turmoil.

FiercePharma13h

Merck halts Gardasil shipments to China, withdraws $11B sales target as demand nosedives

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...

10h

Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

8h

Merck stock trails market as 2025 guidance disappoints, largely due to China

Merck (MRK) stock sank like a stone on Tuesday after the pharmaceutical giant posted poor guidance for the rest of the year.

Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

devdiscourse17h

Key Developments in Global Health: Merck, Pfizer, and Innovative Vaccines

This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results